1. Home
  2. SCPH vs MTA Comparison

SCPH vs MTA Comparison

Compare SCPH & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • MTA
  • Stock Information
  • Founded
  • SCPH 2013
  • MTA 1983
  • Country
  • SCPH United States
  • MTA Canada
  • Employees
  • SCPH N/A
  • MTA N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • MTA
  • Sector
  • SCPH Health Care
  • MTA
  • Exchange
  • SCPH Nasdaq
  • MTA Nasdaq
  • Market Cap
  • SCPH 173.6M
  • MTA 279.4M
  • IPO Year
  • SCPH 2017
  • MTA N/A
  • Fundamental
  • Price
  • SCPH $4.51
  • MTA $4.11
  • Analyst Decision
  • SCPH Strong Buy
  • MTA Hold
  • Analyst Count
  • SCPH 3
  • MTA 1
  • Target Price
  • SCPH $14.00
  • MTA $4.50
  • AVG Volume (30 Days)
  • SCPH 261.6K
  • MTA 429.7K
  • Earning Date
  • SCPH 08-13-2025
  • MTA 08-13-2025
  • Dividend Yield
  • SCPH N/A
  • MTA N/A
  • EPS Growth
  • SCPH N/A
  • MTA N/A
  • EPS
  • SCPH N/A
  • MTA N/A
  • Revenue
  • SCPH $41,982,000.00
  • MTA $6,348,000.00
  • Revenue This Year
  • SCPH $108.95
  • MTA $125.91
  • Revenue Next Year
  • SCPH $73.83
  • MTA $58.98
  • P/E Ratio
  • SCPH N/A
  • MTA N/A
  • Revenue Growth
  • SCPH 138.10
  • MTA 30.38
  • 52 Week Low
  • SCPH $1.94
  • MTA $2.32
  • 52 Week High
  • SCPH $5.65
  • MTA $4.15
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 60.01
  • MTA 65.04
  • Support Level
  • SCPH $3.83
  • MTA $3.75
  • Resistance Level
  • SCPH $4.18
  • MTA $4.14
  • Average True Range (ATR)
  • SCPH 0.17
  • MTA 0.18
  • MACD
  • SCPH -0.02
  • MTA 0.01
  • Stochastic Oscillator
  • SCPH 76.60
  • MTA 95.70

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

Share on Social Networks: